#news #biotech Ardelyx rises on better IBS data and a clearer path to FDA filing

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Ardelyx rises on better IBS data and a clearer path to FDA filing .Small-cap biotech Ardelyx now has a second and more positive phase 3 trial for its constipation-predominant irritable bowel syndrome (IBS-c) drug tenapanor, setting up regulatory filings next year.

from FierceBiotech: Biotech http://ift.tt/2gzXD6m